TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Halterman, Mahoney And Their Grants Go To DCT, Along With Some Program Projects March 17, 1978
TCL Archive Lymphoblastoid If Test Shows Toxicity Not From Impurity, Investigator Says August 8, 1980
